Inventor · disambiguated record
Cheng Li
Also filed as: LI CHENG · Li cheng-ke
10 granted patents·3 pending applications·3 citations·filing 2017–2024
78Inventor score
Files withTRICAN BIOTECHNOLOGY CO LTD4AMPHASTAR NANJING PHARMACEUTICALS INC2QILU PHARMACEUTICAL CO LTD2KBP BIOSCIENCES CO LTD1MEDSHINE DISCOVERY INC1
Top patents by PatentIndex Score
13 records- 0183US11459323B2Monocyclic β-lactam compound for treating bacterial infectionMEDSHINE DISCOVERY INC·Filed 2019·Granted Oct 4, 2022·3 cites·20 claims
- 0266US12054561B2Anti-angiogenesis fusion protein and uses thereofTRICAN BIOTECHNOLOGY CO LTD·Filed 2021·Granted Aug 6, 2024·0 cites·4 claims
- 0362US11180501B2Crystal form of β-lactamase inhibitor and preparation method thereforQILU PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 23, 2021·0 cites·16 claims
- 0460US11518819B2Anti-angiogenesis fusion protein and uses thereofTRICAN BIOTECHNOLOGY CO LTD·Filed 2019·Granted Dec 6, 2022·0 cites·4 claims
- 0559US2025115921A1YEAST GENE ScFIT3 FOR REGULATING AND CONTROLLING CADMIUM RESISTANCE OF ORGANISM AND APPLICATION THEREOFSHANDONG HUANENG POWER GENERATION CO LTD·Filed 2024·Application pending·0 cites
- 0653US10683487B2Myrmecridium flexuosum NUK-21, novel lactose oxidase isolated from Myrmecridium flexuosum NUK-21, and method for conversion of lactose into lactobionic acid by novel lactose oxidaseNAT UNIV KAOHSIUNG·Filed 2018·Granted Jun 16, 2020·0 cites·6 claims
- 0749US12338263B2Antibacterial aminoglycoside derivativesZHUOHE PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Jun 24, 2025·0 cites·2 claims
- 0847US2022144824A1Method for preparing tricyclic compound, and intermediate thereofKBP BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 0947US2020115443A1Bi-functional fusion proteins and uses thereofTRICAN BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1044US10851146B2Method for preparing liraglutide intermediate polypeptideAMPHASTAR NANJING PHARMACEUTICALS INC·Filed 2019·Granted Dec 1, 2020·0 cites·12 claims
- 1142US11390677B2Human anti-CD47 antibodies and uses thereofTRICAN BIOTECHNOLOGY CO LTD·Filed 2019·Granted Jul 19, 2022·0 cites·6 claims
- 1240US12325732B2Pro-insulin aspart structure and method for preparing insulin aspartAMPHASTAR NANJING PHARMACEUTICALS INC·Filed 2018·Granted Jun 10, 2025·0 cites·9 claims
- 1335US10738051B2β-lactamase inhibitorsQILU PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 11, 2020·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Cheng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →